Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Gemcitabine and Cisplatin vs Concurrent Cisplatin in NPC
NCT02460887Phase 3Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2015
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Jun 2015; status: active, not recruiting.
02
Drugs
gemcitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02460887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460887.